A study examines how poor and minority patients are more likely to be diagnosed with cancer in the emergency room, and a cancer survivor considers the lasting effects of chemotherapy.

by Bradley Jones

Forward Look

Outcomes are often evaluated using progression-free survival.

by Jasenka Piljac Zegarac

Forward Look

Study supports use of single-session, higher-dose radiation.

by Jane Langille

CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.

by Kendall K. Morgan

Forward Look

Researchers look for easier ways to screen for colorectal cancer in Nigeria.

by Bradley Jones

Q&A

Biochemist Samuel H. Sternberg describes the limitations, realities and potential of gene-editing technology.

by Marci A. Landsmann

Some cancer drugs being tested in clinical trials do not work the way researchers thought they did, and ringing a bell following radiation therapy may increase distress for patients.

by Kate Yandell

People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.

by Jon Kelvey

Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.

by Emma Yasinski

Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed.

by Ashley P. Taylor